Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 9005-27-0
2. Starch, 2-hydroxyethyl Ether
3. 2-hydroxyethyl Starch
4. (2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2r,3r,4s,5r,6s)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol
5. Hydroxyethyl Starch 130/0.4
6. Starch, 2-hydroxyethyl Ether, Base-hydrolyzed
7. 68512-26-5
8. Chembl1730764
9. Akos030254900
10. Hydroxyethyl Starch (high Mw), European Pharmacopoeia (ep) Reference Standard
11. Hydroxyethyl Starch (medium Mw), European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 580.6 g/mol |
---|---|
Molecular Formula | C22H44O17 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 17 |
Exact Mass | 580.25784993 g/mol |
Monoisotopic Mass | 580.25784993 g/mol |
Topological Polar Surface Area | 267 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 497 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
An intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.
After isovolemic exchange of blood with 500 mL of HES in healthy volunteers, blood volume is maintained for at least 6 hours
Absorption
Peak concentration (C(max), 4.34 mg/mL)
Route of Elimination
Approximately 62 % of HES was excreted as hydroxyethyl starch molecules in urine within 72 hours.
Volume of Distribution
5.9 L.
Clearance
31.4 mL/min
When given intravenously, molecules smaller than the renal threshold (60,000-70,000 daltons) are readily and rapidly excreted in the urine, while molecules with higher molecular weights are metabolized by plasma -amylase prior to excretion via the renal route.
Terminal half-life is 16.1 h. Elimination half-life is 12 h.
Hydroxyethyl starch (HES) is one of the most frequently used plasma substitutes. Recent studies have indicated that HES may reduce capillary leakage.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
A Hydroxyethyl Starch manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyethyl Starch, including repackagers and relabelers. The FDA regulates Hydroxyethyl Starch manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyethyl Starch API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxyethyl Starch manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxyethyl Starch supplier is an individual or a company that provides Hydroxyethyl Starch active pharmaceutical ingredient (API) or Hydroxyethyl Starch finished formulations upon request. The Hydroxyethyl Starch suppliers may include Hydroxyethyl Starch API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyethyl Starch suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydroxyethyl Starch Drug Master File in Korea (Hydroxyethyl Starch KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydroxyethyl Starch. The MFDS reviews the Hydroxyethyl Starch KDMF as part of the drug registration process and uses the information provided in the Hydroxyethyl Starch KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydroxyethyl Starch KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydroxyethyl Starch API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydroxyethyl Starch suppliers with KDMF on PharmaCompass.
A Hydroxyethyl Starch CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxyethyl Starch Certificate of Suitability (COS). The purpose of a Hydroxyethyl Starch CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxyethyl Starch EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxyethyl Starch to their clients by showing that a Hydroxyethyl Starch CEP has been issued for it. The manufacturer submits a Hydroxyethyl Starch CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxyethyl Starch CEP holder for the record. Additionally, the data presented in the Hydroxyethyl Starch CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxyethyl Starch DMF.
A Hydroxyethyl Starch CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxyethyl Starch CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydroxyethyl Starch suppliers with CEP (COS) on PharmaCompass.
Hydroxyethyl Starch Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxyethyl Starch GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxyethyl Starch GMP manufacturer or Hydroxyethyl Starch GMP API supplier for your needs.
A Hydroxyethyl Starch CoA (Certificate of Analysis) is a formal document that attests to Hydroxyethyl Starch's compliance with Hydroxyethyl Starch specifications and serves as a tool for batch-level quality control.
Hydroxyethyl Starch CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxyethyl Starch CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxyethyl Starch may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxyethyl Starch EP), Hydroxyethyl Starch JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxyethyl Starch USP).
LOOKING FOR A SUPPLIER?